Blood Clots

Many clinicians participating in the Medicare Part D program have continued to prescribe warfarin over direct-acting oral anticoagulants, despite evidence that the latter drugs are safer and more effective...

Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19, researchers...

High doses of the anticoagulant reduce the risk of developing the dangerous blood clots that are a hallmark of COVID-19, two new studies confirm.

Patients who take anticoagulants before contracting COVID-19 are 43% less likely to be admitted to the hospital, and those who are given the drugs while hospitalized are less likely to die, according to...

Physicians appear to place lower importance on factors that may lead to diagnosis of pulmonary embolism when evaluating patients with dementia who present with shortness of breath, investigators say.

The agency is requiring a warning label on the arthritis and ulcerative colitis drugs Xeljanz and Xeljanz XR (tofacitinib) and two other drugs in this class, citing an increased risk of adverse health...

Nursing home limits turnover with straight talk about COVID – and plenty of chances to get jabbed … No new cases of rare blood clots reported after UK restricts COVID vaccine to older adults … CDC...

Moderately ill hospitalized COVID-19 patients who receive a full dose of heparin have less need for mechanical ventilation, and improved chances of leaving the hospital, a new trial has found.

First case documented of vaccine-induced blood clot treated with a heparin alternative … Researchers urge improvements in kidney failure predictions for chronically ill elders … People 105 or older...

Although “extremely rare” in each case, the likelihood of a dangerous blood clot condition is eight to 10 times higher following a COVID-19 infection than it is after receiving the J&J vaccine, the...